1 documents found
Information × Registration Number 0125U002127, R & D request Title A 12-week, multicenter, extended active treatment study to evaluate the safety and tolerability of brexpiprazole in the treatment of patients with agitation associated with Alzheimer's dementia Head Skrypnikov Andrii M., д.мед.н. Registration Date 11-04-2025 Organization Poltava State Medical University popup.description1 Investigate active treatment to assess the safety and tolerability of brexpiprazole in the treatment of patients with agitation associated with Alzheimer's dementia popup.nrat_date 2025-04-11 Close
search.res_rk
A 12-week, multicenter, extended active treatment study to evaluate the safety and tolerability of brexpiprazole in the treatment of patients with agitation associated with Alzheimer's dementia
Head: Skrypnikov Andrii M.. A 12-week, multicenter, extended active treatment study to evaluate the safety and tolerability of brexpiprazole in the treatment of patients with agitation associated with Alzheimer's dementia. Poltava State Medical University. № 0125U002127
1 documents found

Updated: 2026-03-24


Роздрукувати цю сторінку